baber/WOPTO huggingface dataset:
Patent WO-2020242757-A9 (WO)
Inventor: JAKUBOV ONDREJ
IPC: H04B1/04
Filed: 2020-05-12
Abstract: In general, techniques are described for limiters used in wireless transmitters. A transmitter comprising a frontend circuit and a backend circuit may perform various aspects of the limiter techniques. The frontend circuit may obtain a data symbol of a plurality of data symbols representative of data to be transmitted wirelessly, and determine an amplitude and a phase representative of the data symbol. The frontend circuit may also transform the phase to a frequency, compare the frequency to a threshold frequency, and adjust, based on the comparison of the frequency to the threshold frequency, the frequency to obtain an adjusted frequency. The backend circuit configured may obtain, based on the amplitude and the adjusted frequency, a wireless signal, and transmit the wireless signal.
Patent WO-2021025952-A9 (WO)
Title: System and method for electronic messaging
Inventor: WOODS JONATHAN
IPC: G06F9/451
Filed: 2020-07-30
Abstract: A system and corresponding method for electronic messaging enable an author to add a plurality of user interface (UI) elements in an arrangement within a UI view, the arrangement defined by the author. Each UI element represents respective content and has respective metadata associated therewith for rendering the respective content within the UI view according to the arrangement at a later time. The UI view is generated, advantageously, within an environment supported by a messaging app, enabling the author to remain in a conversation of the messaging app. The system enables the plurality of UI elements, with the respective content and metadata associated therewith, to be uploaded to a server. The server generates a preview of the UI view that enables aspects of the UI view to be viewed on a recipient device without having to download the UI view to the recipient device.
Patent WO-2021030450-A9 (WO)
Title: Novel lox-1 antibody compositions, lox1 neutralization assay and methods of treatment using same
Inventor: GABRILOVICH DMITRY
IPC: A61P9/04
Filed: 2020-08-12
Abstract: Provided herein is a recombinant antibody or an epitope binding fragment thereof that specifically binds to a lectin-like oxidized low-density lipoprotein (LDL) receptor- 1 (LOX-1) epitope, as well as compositions and methods using these antibodies and fragments for therapeutic and diagnostic protocols.
Patent WO-2023009839-A9 (WO)
Inventor: HANEJKO FRANCIS GARY
IPC: H01F1/12
Filed: 2022-07-29
Abstract: A soft metal composition including a CuOFe 2 O 3  magnetic oxide as well as methods of making and using the same are described. The soft magnetic composite may include, based on total weight of the composite, 95 to 99 weight percent iron, 0.1 to 3 weight percent electrically insulating material, 0.5 to 2 weight percent CuOFe 2 O 3 , and a balance of incidental impurities. The soft metal composition may be used to manufacture stators and rotors for electric motors.
Patent DE-102004044039-A9 (DE)
Title: Verfahren zur Entwicklung und/oder Herstellung von Halbleiter-Chips
Inventor: ELIAN KLAUS
IPC: G03F1/00
Filed: 2004-09-09
Abstract: Die Erfindung betrifft erfindungsgemäß ein Verfahren zur Entwicklung und/oder Herstellung von Halbleiter-Chips mit den Schritten des Entwerfens der chipebenenspezifischen Photomaskenlayouts, der rechnergestützten simulatorischen Entwicklung der chipebenenspezifischen Lithographieprozesse mit Belichtungsoptimierung, Maskenoptimierung und Optimierung des Lithographieprozesses, des Durchführens von Lithographie-Versuchsreihen und des Herstellens des Halbleiter-Chips mit der Schaltung, wobei durch die Lithographie-Simulation für die chemische Reaktion wenigstens eines Säurefängers in Gegenwart einer bei der Lithographie katalytisch wirksamen Säure zu einem Produkt verschiedene Herstellungsparameter und Produkteigenschaften berechnet werden. DOLLAR A Dazu werden (a) eine resultierende räumliche Säureverteilung, (b) eine momentane Produktkonzentration bei Reaktion des Produktes mit im Resist enthaltenden und/oder den Resist umgebenden Reaktanden, (c) eine räumliche Inhibitormatrix für die frei verfügbare Säure mit reaktiven Gruppen eines Polymers (Inhibitor), (d) Resistprofile in Querschnittsform und (e) die Abmessungen der Resistprofile berechnet.
Patent CS-213528-B1 (CS)
Inventor: DVORAK ZDENEK
IPC: F25B1/00
Filed: 1981-01-04
Abstract: Očolon vynálezu je zajištění stability
teplotní úrovně a množství tepla ,
využlvatelnáho při vyšší teplotní úrovni
a dosažení nezávislostí těohto paranetrů
na vnějělch podadLmkáoh·
Podle vynálezu je vysokotlaká kapalinová
potrubí nebo eaoi potrubí rozděleno
do dvou paralelních větví, z nichž
jedna větev prochází výměníkem tepla a
druhá větev jej obchází. V obou větvích
je vestavěn společný regulační orgán,
vytvořený jako trojcestný regulační ventil.
Alternativně mohou 'obě větve vycházet z
Vysokotlakého sběrače při vřazení
čerpadla kapalného chladivá.
Patent DK-167347-B1 (DK)
Inventor: PORCHAM WOLFGANG
IPC: E03D9/08
Filed: 1985-02-20
Granted: 1993-10-18
Abstract: A process for producing silane, whereby silicon tetrafluoride is reacted with magnesium hydride in a melt of alkali or alkaline earth halides under a hydrogen partial pressure which is greater than the dissociation pressure of the magnesium hydride at the temperature of the melt.
Patent IE-55241-B1 (IE)
Title: Solvent extraction
IPC: C22B15/00
Filed: 1983-01-24
Abstract: Reagents formulated by admixture of selected hydroxy aryl ketoxime and hydroxy aryl aldoxime extractants provide for efficient recovery of metal values, especially copper values, by solvent extraction processes. Reagents may include from 0 to about 20 mole percent of a kinetic additive based on ketoxime content and also optionally a modifier of extraction and stripping equilibria in an amount providing a degree of modification of the aldoxime constituent of from about 0.66 to 1.0.
Patent IE-64227-B1 (IE)
Title: Ws-9326a ws-9326b and their derivatives
Inventor: KINO TOHRU
IPC: C12N1/20
Filed: 1989-01-24
Abstract: This application relates to new compounds called WS-9326A, WS-9326B, and their derivatives having valuable pharmaceutical properties and which are obtainable by culturing a WS-9326A and/or WS-9326B producing strain belonging to the genus Streptomyces in nutrient medium and recovering such compounds or salts thereof from the resultant cultured broth. The invention also relates to a process for the production of such compounds and to pharmaceutical compositions containing them or a pharmaceutically acceptable salt thereof as an active ingredient. The invention furthermore relates to a biologically pure culture of the microorgnism Streptomyces violaceoniger No. 9326 (FERM BP-1667).
Patent IE-31978-B1 (IE)
Title: Oligomerisation process
IPC: C07C2/46
Filed: 1968-03-07
Abstract: 1,149,927. Oligomerizing butadiene. GEIGY (U.K.) Ltd. 14 March. 1968 [15 March, 1967], No. 12104/67. Heading C5E. Butadiene is oligomerized by heating in an alkyl cyanide solvent in the presence of a catalyst comprising a reduced form of cobalt (III) acetylacetonate modified by the presence of a minor proportion of methyl methacrylate. The reduced catalyst is suitably prepared by contacting cobalt (III) acetylacetonate in the presence of a portion of butadiene monomer with a reducing agent selected from hydrides of Li, Na, K, Mg, Ca, Zn, B or Al, and alkyl or aryl derivatives of Li, Na, K, Mg, Zn or Al, preferably aluminium triethyl. In the example, the products comprise 3-methyl-1,4,6-heptatriene, 4 - vinyl cyclohexene, 1,5 - cyclooctadiene, 3 - methyl undecatetraene and some higher oligomers. 3-Methyl-1,4,6-heptatriene may be partially hydrogenated to the corresponding diene which may then be co-oligomerized with alpha-olefins, the resulting oligomers when fully hydrogenated being useful functional fluids and lubricants.
[GB1149927A]
Patent IE-46551-B1 (IE)
Title: Diffusion device separation elements
IPC: D01F2/04
Filed: 1978-02-10
Abstract: This application discloses an apparatus and method for preparing an elongated, coreless bundle of homogeneously distributed hollow, generally longitudinally-directed, semipermeable filaments, free of direct mechanical attachment to each other, for use as a fluid separation element in a diffusion device such as a dialyzer. The filaments are positioned in the bundle whereby the majority of the lengths thereof, and the overall directions thereof, define an angle to the longitudinal axes of the said filament bundle. The filaments are positioned in crossing, overlying relation with adjoining filaments, said filaments essentially occupying individual, parallel, flat planes. The filaments define first sets of generally parallel strands defining a first angular relation to said longitudinal axis and second sets of generally parallel strands defining an opposite angular relation to said longitudinal axis, a first filament of a first set being overlaid by a first filament of a second set, which first filament of said second set is, in turn, overlaid by a second filament of said first set, which second filament of said first set is, in turn, overlaid by a second filament of said second set. The said relationship continues throughout the majority of the filaments of the first and second sets to define interleaving releationships, in which the filaments of each set overly the immediatelypreceding filaments of the other associated set, and are overlaid by the immediately-following filaments of said other set, the majority of individual filaments thereof extending across 15 to 50 percent of the width of said filament bundle.
Patent IE-34082-B1 (IE)
Title: A process for the preparation of 3-oxo-19-nor-delta4-steroids via novel nitrogenous 4,5-secosteroids
IPC: C07J1/00
Filed: 1970-04-02
Abstract: 1309651 Steroid synthesis; 4,5-secosteroids F HOFFMANN-LA ROCHE & CO AG 2 April 1970 [4 April 1969] 15632/70 Headings C2C and C2U The invention comprises compounds of Formul VI and VII and a process for preparing compounds of Formula I from compounds of Formula II by reaction sequence ABCDE or ABCDFG in the reaction scheme in which all compounds are d, l or dl, M is the remainder of the D ring of the steroid; R is OH, C 1-7 alkoxy or -NXY where X and Y are each C 1-7 alkyl; R<SP>1</SP> is primary C 1-5 alkyl, R<SP>2</SP>, R<SP>3</SP> and R<SP>5</SP> are each H or C 1-7 alkyl; and R<SP>6</SP> is H, monocyclic aryl- C 1-7 -alkyl, acyl or -CR<SP>7</SP>R<SP>8</SP>R<SP>9</SP> where R<SP>7</SP>, R<SP>8</SP> and R<SP>9</SP> are each C 1-7 alkyl. Reaction sequence A<SP>1</SP>B<SP>1</SP> is alternative to AB but does not form part of the invention and is not exemplified. The reaction steps are effected as follows: (A) heat and/or acid; (A<SP>1</SP>) and (B) hydrogenation with a noble metal catalyst in the presence of a base; (B<SP>1</SP>) heat and acid; (C) reaction with R-NH 2 or a salt thereof; (D) selective oxidation, e.g. with CrO 3 /acetone, metal alkoxide, silver carbonate, or CrO 3 /H 2 SO 4 /N,N-dialkylalkanamide; (E) aqueous acid in an inert watermiscible organic solvent; (F) reaction with a reactive carbonyl compound; e.g. acetone, pyruvic acid or levulinic acid; (G) cyclization which may be acid- or base-catalysed. A 17 oxo group (steroid numbering) in a compound of Formula III may be converted to an =NR group during step (C) and regenerated during step (E) or (G). Alternatively said 17- oxo group may be reduced to a 17#-hydroxy group or converted to a 17α-alkynyl-17#- hydroxy group immediately prior to step C. A 17-hydroxy group in a compound of Formula VI may be converted to an oxo group during step (D). Compounds of Formul III and IV comprise the subject-matter of Specification 1,309,652. Reference has been directed by the Comptroller to Specification 1,207,048.
[GB1309651A]
Patent IE-57228-B1 (IE)
Title: Installation of the superstructure of an offshore platform
IPC: E02B17/00
Filed: 1986-02-17
Abstract: A process and apparatus for installing the enbloc superstructure of an offshore platform on the fixed legs emerging from water of the lower structure or jacket including loading the whole superstructure on a vertically movable support platform provided on the deck of a semisubmersible raft or barge, completely submerging the raft in the vicinity of the jacket, the stability being maintained by vertical buoyancy tanks on the raft deck, and lifting the support platform and the superstructure by activating related hydraulic lift cylinders, to a height higher than that of the protruding ends of the jacket leg, independently from wave-motion of sea. Subsequently, cylindrical lift pillars slide, by means of hydropneumatic jacks, within tubular columns provided in the superstructure until the conical ends of the pillars enter corresponding seats in the jacket legs and, during a moment of smooth sea, the superstructure is lifted to the desired height using the hydropneumatic jacks, while at the same time, the support platform is rapidly lowered, and the raft is ballasted.
Patent IE-35421-B1 (IE)
Title: Quinoxaline derivatives
IPC: C07D491/04
Filed: 1971-07-02
Abstract: 1351342 Quinoxaline derivatives CIBAGEIGY AG 30 June 1971 [6 July 1970 4 June 1971] 30691/71 Heading C2C Novel compounds (I) (including salts, optical isomers and racemates thereof) where R 1 and R 2 are H, alkyl, alkoxy, halogen, CF 3 or NO 2 or taken together signify alkylenedioxy, R 3 and R 4 are optionally substituted amidino, a monovalent or taken together signify a divalent optionally substituted hydrocarbon or acyl residue separating the sulphur atoms by at most 4 carbons or R 3 and R 4 together signify a direct bond, R 5 and R 6 are H or alkyl or taken together signify -(CH 2 ) n - where n is 1 to 8, are made by standard methods, especially utilizing the corresponding 2,3-bis-(bromomethyl or -mercaptomethyl) - quinoxalines; eyelizations are also utilized. Pharmaceutical preparations especially active against viruses contain (I) as active ingredient; administration may be enterally, parenterally or topically.
[GB1351342A]
Patent IE-60605-B1 (IE)
Title: 3'-azido-3'-deoxythymidine controlled-release formulations
Inventor: JONES HARRY PHILLIP
IPC: A61K9/54
Filed: 1988-03-25
Abstract: The invention relates to pharmaceutical formulations comprising discrete units of zidovudine provided with a controlled release coating in which the said units are preferably in the form of spheroids.
Patent LU-92960-B1 (LU)
Title: Capacitive measurement circuit with sensor wiring diagnostics
Inventor: LAMESCH LAURENT
IPC: H03K17/955
Filed: 2016-01-26
Granted: 2017-08-07
Abstract: A capacitance measurement circuit (28) for determining a sense current of a capacitive sensor (12) with a sense electrode and a guard electrode, comprises a periodic signal voltage source (24), a sense current measurement circuit (30) configured for determining the sense current with reference to a reference voltage, at least one remotely controllable switch member (40), wherein in the first switching state, the at least one switch member (40) electrically connects the sense current measurement circuit (30) to the periodic measurement voltage for providing a first reference voltage, and in the second switching state, the at least one switch member (40) electrically connects the sense current measurement circuit (30) to a second reference voltage that is different from the first reference voltage. (Fig. 1) 92960
Patent MA-31053-B1 (MA)
Inventor: EL ABIARI KARIM
IPC: B25G3/14
Filed: 2008-06-12
Abstract: عندما نشتري مكشطة أو مكنسة بعصيهما،تتقادم أسنان اللولب بسهولة.لهذا قمت باختراع توصيل من البلاستيك لتفادى شراء كل مرة عصا بأسنان اللولب في طرفها:وتضم هذه الوصلة جزء أسطوانيا دون أسنان اللولب وجزء بأسنان اللولب في الجزء الخارجي.
Patent MA-33073-B1 (MA)
Title: Litiere hydrophobe a base de fibres de chlorure de polyvinyl
Inventor: BELMIR HIDAR
IPC: A01K1/015
Filed: 2009-02-23
Abstract: Il s'agit d'une litière à base de chlorure de polyvinyle (pvc), elle est conçue particulièrement pour les chevaux mais peut être adaptée aux autres animaux et volailles.Les fibres sont plantées sur des supports en bois ou en plastique lesquels sont fixés sur une structure métallique ou plastique surélevée du sol et perforée permettant l'évacuation des masses liquides.La structure métallique ou plastique est permanente, posée au sol et adaptable aux différentes surfaces à couvrir.Il s'agit d'une litière permanente sous forme de modules.
Patent MA-30811-B1 (MA)
Title: Compositions therapeutiques permettant d'augmenter l'effet d'une therapie aux anticorps contre le recepteur du facteur de croissance epidermique
Inventor: FERNANDEZ MOLINA LUIS ENRIQUE
Filed: 2009-04-23
Abstract: CETTE INVENTION CONCERNE DES COMPOSITIONS THÉRAPEUTIQUES SPÉCIFIQUES AUGMENTANT L'EFFICACITÉ DE LA THÉRAPIE AUX ANTICORPS MONOCLONAUX (ACMS) CONTRE LE RÉCEPTEUR DU FACTEUR DE CROISSANCE ÉPIDERMIQUE (EGFR, DE L'ANGLAIS 'EPIDERMAL GROWTH FACTOR RECEPTOR') ET DES INTERFÉRONS (INFS) DE TYPE I (A/ß).
Patent MA-30901-B1 (MA)
Title: Therapie de combinaison sequentielle
Inventor: JAIN RAKESH K
Filed: 2009-05-14
Abstract: LA PRÉSENTE INVENTION CONCERNE DE NOUVEAUX PROCÉDÉS DESTINÉS AU TRAITEMENT DE TROUBLES LIÉS À L'ANGIOGENÈSE. LESDITS TROUBLES LIÉS À L'ANGIOGENÈSE SONT TRAITÉS PAR L'ADMINISTRATION D'UN AGENT DE LIAISON ECTODOMAINE TIE1 ET D'UN AGENT ANTAGONISTE VEGF.
Patent MA-31753-B1 (MA)
Inventor: VLASSENBROECK ILSE
IPC: C12Q1/68
Filed: 2010-04-01
Abstract: L'INVENTION CONCERNE UN OLIGONUCLÉOTIDE, UNE AMORCE OU UNE SONDE COMPRENANT LA SÉQUENCE NUCLÉOTIDIQUE D'UNE QUELCONQUE SEQ ID NO. 5, 6, 7, 2, 3, 4, 8, 9, 11, 12, 13, 14, 15, 16, 17, 18, 19 OU 25. LES OLIGONUCLÉOTIDES SONT UTILISÉS DANS LA DÉTECTION DE L'ÉTAT DE MÉTHYLATION D'UN GÈNE, EN PARTICULIER LE GÈNE MAGE-A3. LES OLIGONUCLÉOTIDES SONT, DE PLUS, UTILISÉS DANS DES PAIRES D'AMORCES, DES KITS ET DES MÉTHODES DE DÉTERMINATION DE L'ÉTAT DE MÉTHYLATION DU GÈNE MAGE-A3 ET DANS LE DIAGNOSTIC DU CANCER, L'ORIENTATION THÉRAPEUTIQUE ET LA SÉLECTION DE SUJETS À DES FINS DE TRAITEMENT. L'AMORCE OU LA SONDE PEUVENT COMPRENDRE UNE STRUCTURE EN BOUCLE OU EN ÉPINGLE À CHEVEUX ET PEUVENT ÊTRE UTILISÉES DANS UNE PCR SPÉCIFIQUE À LA MÉTHYLATION EN TEMPS RÉEL.
Patent MA-32295-B1 (MA)
Inventor: PITTERNA THOMAS
IPC: C07D401/14
Filed: 2010-11-11
Abstract: A compound of formula (I): wherein R1 is pyrid-4-yl optionally substituted by one to four substituents independently selected from halogen, C1-3 alkyl or C1-3 haloalkyl; R2 is hydrogen, halogen, C1-4 haloalkyl or C1-4 haloalkoxy; R3 is trifluoromethyl, difluoromethyl or difluoromethoxy and R4 is hydrogen, fluoro or chloro, or R3 is fluoro, chloro or bromo and R4 is fluoro, chloro or trifluoromethyl; and R5 is hydrogen or halogen; or salts or N-oxides thereof. Furthermore, the present invention relates to intermediates used to prepare compounds of formula (I), to methods of using them to combat and control insect, acarine, mollusc and nematode pests and to insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them.
Patent MA-34115-B1 (MA)
Inventor: LARBI SAADALLAH
IPC: A45C13/36
Filed: 2011-09-16
Abstract: عنوان هذا الجهاز هو cartanse، وهو مقبض لحمل الأكياس الصغيرة ذات المقابض الرقيقة.يمكن وضعه بين اليد ومقبض الكيس لتجنب الآلام التي يولدها حمل الأكياس الثقيلة ذات المقبض الرقيق. إنه قبل كل شيء من وسائط الإعلانات للشركات الراغبة في الإعلان عن منتجاتها أو خدماتها و ماركاتها، ومواقع الإنترنيت، والعناوين، و العروض الترويجية ومختلف أنواع الإعلانات
Patent MA-34839-B1 (MA)
Title: Dihydrofuranes condensés en tant que modulateurs de gpr119 pour le traitement du diabète, de l'obésité et de troubles apparentes
Inventor: HIMMELSBACH FRANK
IPC: A61K31/454
Filed: 2012-01-20
Abstract: LA PRÉSENTE INVENTION CONCERNE DES COMPOSÉS DE FORMULE GÉNÉRALE (I), DANS LAQUELLE LES GROUPES R1, LP, LQ, X1, X2, X3, A, N ET M SONT TELS QUE DÉFINIS DANS LA DESCRIPTION, QUI ONT DES PROPRIÉTÉS PHARMACOLOGIQUES UTILES, ET EN PARTICULIER SE LIENT AU RÉCEPTEUR GPR119 ET MODULENT SON ACTIVITÉ.
Patent MA-35072-B1 (MA)
Title: Distributeur
Inventor: SPORRE THORBURN ANNIE
IPC: A47K10/42
Filed: 2011-04-05
Abstract: La présente invention a trait à une boîte distributrice (200, 300) qui est dotée d'une forme rectangulaire modifiée et de parois d'extrémité en forme de feuille (236, 237; 336, 337) et de parois principales partiellement incurvées (250, 25; 350, 351) qui peuvent former des moitiés de la boîte distributrice (200, 300) configurées de façon symétrique ou non symétrique. La première paroi principale (250; 350) est pourvue d'une surface sensiblement plate qui s'étend depuis un premier côté latéral (238; 338) de la boîte distributrice (200, 300) et qui se transforme en une surface incurvée dans la direction allant du premier côté latéral (238; 338) vers un second côté latéral (239; 339) de la boîte distributrice. La seconde paroi principale (251; 351) est pourvue d'une surface sensiblement plate correspondante sur le second côté latéral (239; 339) qui se transforme en une surface incurvée dans la direction allant vers le premier côté latéral (238; 338).
Patent CS-228372-B1 (CS)
Inventor: SYKORA BOHUMIL RNDR
IPC: H04R17/00
Filed: 1982-03-10
Abstract: Vynález spadá do oboru snímání mechanického
chvění a jeho převodu na elektrický
signál při zachování možnosti dalšího
elektronického zpracování.
Ve vnitřním prostoru pouzdra je umístěn
citlivý prvek, například destička z piezon
elektrického materiálu, a to tak, že s pouzdrem
je spojen pouze v oblasti svého těžiš­
tě, přičemž ostatní části citlivého prvku
jsou volně uloženy ve vnitřním prostoru
pouzdra. Pro odstínění rušivých vlivů může
být pouzdro opatřeno vodivými stínícími povrchy
vně nebo' uvnitř, nebo může býti kovové.
Vnitřní prostor pouzdra lze vyplnit
viskózním nebo viskóznněelastickým mate
Patent CS-244086-B1 (CS)
Inventor: DVORAK VLADIMIR
IPC: F16J1/10
Filed: 1985-03-20
Abstract: Podstata řešení spočívá v nové konstrukci
speciálního silentbloku, kde
vnitřní pružný prvek je volně navléknut
na Čepu plunžru a z obou stran zajištěn
zkosenými plochami převlečného kroužku
a dutého šroubu nebo matice.
Patent CS-230985-B1 (CS)
Inventor: KARPISEK JIRI
IPC: G21D1/00
Filed: 1983-03-24
Abstract: Účelem vynálezu je zrovnoměrnění průtoku
po celé ploše vstupních sektorů napojovacího
průřezu mezi vstupní komorou a tělesem
separátorů mokry páry parních turbin
u jaderných elektráren.
Účelu vynálezu se dosáhne tím, že rozváděči
přepážka sestává z horní stěny, dvou
vnitřních bočních stěn končících v napojovacím
průřezu dvěma vnitřními odtokovými
hranami a dvou vnitřních bočních stěn končících
v napojovacím průřezu dvěma vnějšími
odtokovými hranami, přičemž dvě vnitřní
odtokové hrany uzavírají v napojovacím průřezu
nejméně jeden vstupní sektor a dvě
vnější odtokové hrany navazují v napojovacím
průřezu na obrys dvou dalších vstupních
sektorů, které leží mimo rozváděči
přepážku.
Patent CS-220951-B1 (CS)
Inventor: PIKLER ALEXANDER
IPC: D01F1/10
Filed: 1981-03-25
Abstract: Vynález sipadá do odboru spracovania
syntetických vlákien. Rieši spůsob přípravy
syntetických vlákien s antimikróbnou účinnosťou
spočívajúci v přidaní 0,01 až 0,3 %
hmlotniostných butylderivátu kysličníka cí-
ničitého všeobecného vzorca
(Rl )xSnyR2,
kde
Ri je butyl, R2 je kyslík, x je 2 alebo, 3
a y je 2 k materiálu pre polyamidové, polyesterové,
polyolefínové a polyvinylové vlákna,
a to vo formě kvapaliny alebo prášku.
Podstatou spůslobu je, že polymérna zmes
s přidaným butylderivátom kysličníka cíničitého
sa ďalej zvlákňuje extruderovým spů-
sobom při teplotách 240 až 265 °C.
Patent CS-231770-B1 (CS)
Inventor: ISTVANFY OTAKAR
IPC: G01N30/62
Filed: 1982-03-29
Abstract: Vynález se týlká selektivního kapkového
detektoru, který sestává z kapiláry, spojené
pružnou hadičkou s pevným ramenem,
pravoúhle ohrnutým do svislé polohy, opatřeným
na konci kruhovou destičkou, přičemž
rameno je připevněno k piezoelektrickému
krystalu, který je spojen vodiči s převodníkem.
Detektor je urč&n pro stanovení
povrchově aktivních láteik pro kapalinovou
chromatografi, pro průmyslové a zemědělské
účely a pro ochranu životního prostředí.
Detektor transformuje změnu mechanického
namáhání, způsobenou odtrhnutím kapek,
v elektrické signály, které se vyhodnocují.